Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells
- 1 November 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (11), 1522-1524
- https://doi.org/10.1136/annrheumdis-2020-217316
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosisBlood, 2017
- Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cellsBlood, 2017
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesBlood, 2016
- Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester diseaseBlood, 2016
- Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaBlood, 2015
- Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester DiseaseJournal of Clinical Oncology, 2015
- Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patientsBlood, 2011
- Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytesProceedings of the National Academy of Sciences of the United States of America, 2007